Exact Mass: 617.2809124
Exact Mass Matches: 617.2809124
Found 280 metabolites which its exact mass value is equals to given mass value 617.2809124
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Rotigaptide
8-Deacetylyunaconitine
Ala Arg Trp Trp
Ala Trp Arg Trp
Ala Trp Trp Arg
Glu Phe His Trp
Glu Phe Trp His
Glu His Phe Trp
Glu His Trp Phe
Glu Lys Arg Trp
Glu Lys Trp Arg
Glu Gln Arg Trp
Glu Gln Trp Arg
Glu Arg Lys Trp
Glu Arg Gln Trp
Glu Arg Trp Lys
Glu Arg Trp Gln
Glu Trp Phe His
Glu Trp His Phe
Glu Trp Lys Arg
Glu Trp Gln Arg
Glu Trp Arg Lys
Glu Trp Arg Gln
Phe Glu His Trp
Phe Glu Trp His
Phe His Glu Trp
Phe His Trp Glu
Phe Trp Glu His
Phe Trp His Glu
His Glu Phe Trp
His Glu Trp Phe
His Phe Glu Trp
His Phe Trp Glu
His Ile Trp Tyr
His Ile Tyr Trp
His Leu Trp Tyr
His Leu Tyr Trp
His Trp Glu Phe
His Trp Phe Glu
His Trp Ile Tyr
His Trp Leu Tyr
His Trp Tyr Ile
His Trp Tyr Leu
His Tyr Ile Trp
His Tyr Leu Trp
His Tyr Trp Ile
His Tyr Trp Leu
Ile His Trp Tyr
Ile His Tyr Trp
Ile Asn Trp Trp
Ile Trp His Tyr
Ile Trp Asn Trp
Ile Trp Trp Asn
Ile Trp Tyr His
Ile Tyr His Trp
Ile Tyr Trp His
Lys Glu Arg Trp
Lys Glu Trp Arg
Lys Arg Glu Trp
Lys Arg Trp Glu
Lys Trp Glu Arg
Lys Trp Arg Glu
Leu His Trp Tyr
Leu His Tyr Trp
Leu Asn Trp Trp
Leu Trp His Tyr
Leu Trp Asn Trp
Leu Trp Trp Asn
Leu Trp Tyr His
Leu Tyr His Trp
Leu Tyr Trp His
Asn Ile Trp Trp
Asn Leu Trp Trp
Asn Trp Ile Trp
Asn Trp Leu Trp
Asn Trp Trp Ile
Asn Trp Trp Leu
Gln Glu Arg Trp
Gln Glu Trp Arg
Gln Arg Glu Trp
Gln Arg Trp Glu
Gln Val Trp Trp
Gln Trp Glu Arg
Gln Trp Arg Glu
Gln Trp Val Trp
Gln Trp Trp Val
Arg Ala Trp Trp
Arg Glu Lys Trp
Arg Glu Gln Trp
Arg Glu Trp Lys
Arg Glu Trp Gln
Arg Lys Glu Trp
Arg Lys Trp Glu
Arg Gln Glu Trp
Arg Gln Trp Glu
Arg Trp Ala Trp
Arg Trp Glu Lys
Arg Trp Glu Gln
Arg Trp Lys Glu
Arg Trp Gln Glu
Arg Trp Trp Ala
Ser Trp Tyr Tyr
Ser Tyr Trp Tyr
Ser Tyr Tyr Trp
Val Gln Trp Trp
Val Trp Gln Trp
Val Trp Trp Gln
Trp Ala Arg Trp
Trp Ala Trp Arg
Trp Glu Phe His
Trp Glu His Phe
Trp Glu Lys Arg
Trp Glu Gln Arg
Trp Glu Arg Lys
Trp Glu Arg Gln
Trp Phe Glu His
Trp Phe His Glu
Trp His Glu Phe
Trp His Phe Glu
Trp His Ile Tyr
Trp His Leu Tyr
Trp His Tyr Ile
Trp His Tyr Leu
Trp Ile His Tyr
Trp Ile Asn Trp
Trp Ile Trp Asn
Trp Ile Tyr His
Trp Lys Glu Arg
Trp Lys Arg Glu
Trp Leu His Tyr
Trp Leu Asn Trp
Trp Leu Trp Asn
Trp Leu Tyr His
Trp Asn Ile Trp
Trp Asn Leu Trp
Trp Asn Trp Ile
Trp Asn Trp Leu
Trp Gln Glu Arg
Trp Gln Arg Glu
Trp Gln Val Trp
Trp Gln Trp Val
Trp Arg Ala Trp
Trp Arg Glu Lys
Trp Arg Glu Gln
Trp Arg Lys Glu
Trp Arg Gln Glu
Trp Arg Trp Ala
Trp Ser Tyr Tyr
Trp Val Gln Trp
Trp Val Trp Gln
Trp Trp Ala Arg
Trp Trp Ile Asn
Trp Trp Leu Asn
Trp Trp Asn Ile
Trp Trp Asn Leu
Trp Trp Gln Val
Trp Trp Arg Ala
Trp Trp Val Gln
Trp Tyr His Ile
Trp Tyr His Leu
Trp Tyr Ile His
Trp Tyr Leu His
Trp Tyr Ser Tyr
Trp Tyr Tyr Ser
Tyr His Ile Trp
Tyr His Leu Trp
Tyr His Trp Ile
Tyr His Trp Leu
Tyr Ile His Trp
Tyr Ile Trp His
Tyr Leu His Trp
Tyr Leu Trp His
Tyr Ser Trp Tyr
Tyr Ser Tyr Trp
Tyr Trp His Ile
Tyr Trp His Leu
Tyr Trp Ile His
Tyr Trp Leu His
Tyr Trp Ser Tyr
Tyr Trp Tyr Ser
Tyr Tyr Ser Trp
Tyr Tyr Trp Ser
Rotigaptide
C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent
Benzeneacetamide, N-((4-hydroxy(1,1-biphenyl)-3-yl)methyl)-3-(2-(((2R)-2-hydroxy-2-(4-hydroxy-3-((methylsulfonyl)amino)phenyl)ethyl)amino)-2-methylpropyl)-
5-[[4-[5-[[4-[5-[Acetyl(hydroxy)amino]pentylamino]-4-oxobutanoyl]-hydroxyamino]pentylamino]-4-oxobutanoyl]-hydroxyamino]pentylazanium;iron
platensimycin B4 methyl ester
A polycyclic cage that is the methyl ester derivative of platensimycin B4. It is isolated from Streptomyces platensis.
N-[(4R,7R,8S)-5-[(2,5-difluorophenyl)methyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-methoxybenzenesulfonamide
4-[3-[(3S)-2-[(S)-tert-butylsulfinyl]-3-(2-hydroxyethyl)-6-[(4-methyl-1-piperazinyl)-oxomethyl]-1,3-dihydropyrrolo[3,4-c]pyridin-4-yl]phenyl]-N,N-dimethylbenzamide
N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(1-naphthalenylamino)-oxomethyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-morpholinyl)propanamide
1-(3,5-dimethyl-4-isoxazolyl)-3-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]urea
N-[(3R,9S,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-[oxo(pyridin-4-yl)methyl]amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-pyridinecarboxamide
N-[(3S,9R,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-[oxo(pyridin-4-yl)methyl]amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-pyridinecarboxamide
1-(3,5-dimethyl-4-isoxazolyl)-3-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]urea
N-[(3S,9R,10R)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-[oxo(pyridin-4-yl)methyl]amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-pyridinecarboxamide
1-(3,5-dimethyl-4-isoxazolyl)-3-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]urea
N-[(3S,9R,10S)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-[oxo(pyridin-4-yl)methyl]amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-pyridinecarboxamide
N-[(3S,9S,10S)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-[oxo(pyridin-4-yl)methyl]amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-pyridinecarboxamide
4-[3-[(3R)-2-[(R)-tert-butylsulfinyl]-3-(2-hydroxyethyl)-6-[(4-methyl-1-piperazinyl)-oxomethyl]-1,3-dihydropyrrolo[3,4-c]pyridin-4-yl]phenyl]-N,N-dimethylbenzamide
3-[3-[(3S)-2-[(S)-tert-butylsulfinyl]-3-(2-hydroxyethyl)-6-[(4-methyl-1-piperazinyl)-oxomethyl]-1,3-dihydropyrrolo[3,4-c]pyridin-4-yl]phenyl]-N,N-dimethylbenzamide
N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(1-naphthalenylamino)-oxomethyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-morpholinyl)propanamide
N-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(1-naphthalenylamino)-oxomethyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-morpholinyl)propanamide
N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(1-naphthalenylamino)-oxomethyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-morpholinyl)propanamide
N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(1-naphthalenylamino)-oxomethyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-morpholinyl)propanamide
N-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(1-naphthalenylamino)-oxomethyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-morpholinyl)propanamide
N-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(1-naphthalenylamino)-oxomethyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-morpholinyl)propanamide
1-(3,5-dimethyl-4-isoxazolyl)-3-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]urea
1-(3,5-dimethyl-4-isoxazolyl)-3-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]urea
N-[(3R,9R,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-[oxo(pyridin-4-yl)methyl]amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-pyridinecarboxamide
1-(3,5-dimethyl-4-isoxazolyl)-3-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]urea
1-(3,5-dimethyl-4-isoxazolyl)-3-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]urea
N-[(3R,9S,10S)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-[oxo(pyridin-4-yl)methyl]amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-pyridinecarboxamide
N-[(3S,9R,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-[oxo(pyridin-4-yl)methyl]amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-pyridinecarboxamide
N-[(3R,9S,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-[oxo(pyridin-4-yl)methyl]amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-pyridinecarboxamide
N-[(3S,9S,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-[oxo(pyridin-4-yl)methyl]amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-pyridinecarboxamide
N-[(3R,9R,10R)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-[oxo(pyridin-4-yl)methyl]amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-pyridinecarboxamide
N-[(3R,9S,10R)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-[oxo(pyridin-4-yl)methyl]amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-pyridinecarboxamide
N-[(3S,9S,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-[oxo(pyridin-4-yl)methyl]amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-pyridinecarboxamide
N-[(3R,9R,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-[oxo(pyridin-4-yl)methyl]amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-pyridinecarboxamide
3-[3-[(3R)-2-[(R)-tert-butylsulfinyl]-3-(2-hydroxyethyl)-6-[(4-methyl-1-piperazinyl)-oxomethyl]-1,3-dihydropyrrolo[3,4-c]pyridin-4-yl]phenyl]-N,N-dimethylbenzamide
Cyclo(RADfK)
Cyclo(RADfK) is a selective α(v)β(3) integrin ligand that has been extensively used for research, therapy, and diagnosis of neoangiogenesis.
21-chloro-15,16,33,33-tetramethyl-24-methylidene-10-(prop-1-en-2-yl)-7,11,32-trioxa-18-azadecacyclo[25.4.2.0²,¹⁶.0⁵,¹⁵.0⁶,⁸.0⁶,¹².0¹⁷,³¹.0¹⁹,³⁰.0²²,²⁹.0²⁵,²⁸]tritriaconta-17(31),19,21,29-tetraene-5,9-diol
(4r,5r,6s,7s,8r,18s)-8-(acetyloxy)-5,7,14-trihydroxy-6,16,18-trimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl benzoate
3-[(2s)-4-[(2e,4e,6s)-6-[(2s,5r,6r)-1,6-dimethyl-8,9-dioxaspiro[bicyclo[3.3.1]nonane-2,2'-oxiran]-3-en-7-yl]-4-methylhepta-2,4-dienoyl]-1-(5-hydroxy-6-methyloxan-2-yl)-3,5-dioxopyrrolidin-2-yl]propanoic acid; ethane
14-benzoyl-8-o-methyl-aconine i
{"Ingredient_id": "HBIN001369","Ingredient_name": "14-benzoyl-8-o-methyl-aconine i","Alias": "NA","Ingredient_formula": "C33H47NO10","Ingredient_Smile": "CCN1CC2(C(CC(C34C2C(C(C31)C5(C6C4CC(C6OC(=O)C7=CC=CC=C7)(C(C5O)OC)O)OC)OC)OC)O)COC","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "2248","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
8-deacetylyunaconitine
{"Ingredient_id": "HBIN013693","Ingredient_name": "8-deacetylyunaconitine","Alias": "NA","Ingredient_formula": "C33H47NO10","Ingredient_Smile": "CCN1CC2(C(CC(C34C2C(C(C31)C5(CC(C6(CC4C5C6OC(=O)C7=CC=C(C=C7)OC)O)OC)O)OC)OC)O)COC","Ingredient_weight": "617.7 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "4791","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "137706281","DrugBank_id": "NA"}